FR2378793A1 - Nouvelle substance a activite biologique, son procede de preparation et son application pharmacologique - Google Patents

Nouvelle substance a activite biologique, son procede de preparation et son application pharmacologique

Info

Publication number
FR2378793A1
FR2378793A1 FR7802479A FR7802479A FR2378793A1 FR 2378793 A1 FR2378793 A1 FR 2378793A1 FR 7802479 A FR7802479 A FR 7802479A FR 7802479 A FR7802479 A FR 7802479A FR 2378793 A1 FR2378793 A1 FR 2378793A1
Authority
FR
France
Prior art keywords
substance
biological activity
preparation process
new substance
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7802479A
Other languages
English (en)
French (fr)
Other versions
FR2378793B1 (en:Method
Inventor
Motoyuki Yajima
Koichi Hosoda
Chikanori Tomioka
Michio Ui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaken Pharmaceutical Co Ltd
Original Assignee
Kakenyaku Kako KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kakenyaku Kako KK filed Critical Kakenyaku Kako KK
Publication of FR2378793A1 publication Critical patent/FR2378793A1/fr
Application granted granted Critical
Publication of FR2378793B1 publication Critical patent/FR2378793B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
FR7802479A 1977-02-01 1978-01-30 Nouvelle substance a activite biologique, son procede de preparation et son application pharmacologique Granted FR2378793A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1039777A JPS5396392A (en) 1977-02-01 1977-02-01 Active substance for increasing secretion of insulin

Publications (2)

Publication Number Publication Date
FR2378793A1 true FR2378793A1 (fr) 1978-08-25
FR2378793B1 FR2378793B1 (en:Method) 1982-10-22

Family

ID=11748989

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7802479A Granted FR2378793A1 (fr) 1977-02-01 1978-01-30 Nouvelle substance a activite biologique, son procede de preparation et son application pharmacologique

Country Status (19)

Country Link
US (1) US5000953A (en:Method)
JP (1) JPS5396392A (en:Method)
AU (1) AU513963B2 (en:Method)
BE (1) BE863477A (en:Method)
CA (1) CA1105863A (en:Method)
CH (1) CH640244A5 (en:Method)
CS (1) CS216547B2 (en:Method)
DE (1) DE2803397A1 (en:Method)
DK (1) DK152058B (en:Method)
ES (1) ES467067A1 (en:Method)
FR (1) FR2378793A1 (en:Method)
GB (1) GB1569046A (en:Method)
HU (1) HU179497B (en:Method)
IE (1) IE46649B1 (en:Method)
NL (1) NL7801137A (en:Method)
NZ (1) NZ186361A (en:Method)
SE (1) SE7801106L (en:Method)
SU (1) SU871721A3 (en:Method)
ZA (1) ZA7855B (en:Method)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0125892A3 (en) * 1983-05-11 1986-01-15 Kaken Pharmaceutical Co., Ltd. Islets-activating protein derivatives

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457109A (en) * 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
US6143786A (en) * 1999-02-02 2000-11-07 Novartis Nutrition Ag Oral arginine and insulin secretion
AU2001254621A1 (en) * 2000-05-05 2001-11-20 K.U. Leuven R And D Critical illness neuropathy
US6986882B2 (en) * 2002-01-17 2006-01-17 Astrazeneca Ab Therapy for functional dyspepsia
US20030199445A1 (en) * 2002-02-07 2003-10-23 Knudsen Lotte Bjerre Use of GLP-1 compound for treatment of critically ill patients

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CA1978 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0125892A3 (en) * 1983-05-11 1986-01-15 Kaken Pharmaceutical Co., Ltd. Islets-activating protein derivatives

Also Published As

Publication number Publication date
SE7801106L (sv) 1978-08-02
ES467067A1 (es) 1978-11-01
DE2803397A1 (de) 1978-08-03
AU3285478A (en) 1979-08-09
NL7801137A (nl) 1978-08-03
FR2378793B1 (en:Method) 1982-10-22
SU871721A3 (ru) 1981-10-07
GB1569046A (en) 1980-06-11
CS216547B2 (en) 1982-11-26
HU179497B (en) 1982-10-28
DK152058B (da) 1988-01-25
ZA7855B (en) 1978-11-29
IE46649B1 (en) 1983-08-10
DE2803397C2 (en:Method) 1990-01-25
JPS5396392A (en) 1978-08-23
IE780205L (en) 1978-08-01
DK45378A (da) 1978-08-02
JPS5635154B2 (en:Method) 1981-08-14
CA1105863A (en) 1981-07-28
BE863477A (fr) 1978-07-31
CH640244A5 (en) 1983-12-30
US5000953A (en) 1991-03-19
NZ186361A (en) 1980-10-08
AU513963B2 (en) 1981-01-15

Similar Documents

Publication Publication Date Title
FR2361415A1 (fr) Nouvelle preparation de tannin fixe par adsorption physique a un support, son procede de preparation et ses applications
NO302414B1 (no) Analogifremgangsmåte for fremstilling av heterocykliske forbindelser
FI882249A0 (fi) Tvaerbundet, vattenoloesligt glukosisomeras och foerfarande foer framstaellning daerav.
FR2378793A1 (fr) Nouvelle substance a activite biologique, son procede de preparation et son application pharmacologique
IT1164025B (it) Procedimento di produzione di una sostanza presentante un'attivita' batteriostatica
FR2620699B1 (fr) Procede de synthese d'alpha amino acides n alkyles et de leurs esters. application a la synthese de carboxyalkyl dipeptides
AU8417091A (en) Biologically active compound, a process for the preparation thereof and use of the same
FR2393809A1 (fr) Substance proteinique active et son application pharmacologique
Newton Antibiotics from a strain of B. subtilis: bacilipin A and B and bacilysin
FR2386515A1 (fr) Procede pour la preparation de pyroglutamyl-ala-lys-ser-gln-gly-ser-asn
BG52073B2 (en) Method for the preparation of recombinant human noncystein -interferon, free of n-end methionine
BE902257A (fr) Procede de praparation du d-glucose et de produits d'hydrolyse de l'amidon.
NO920555D0 (no) Polyhydroksycyklopentanderivater, fremgangsmaate til fremstilling derav samt terapeutisk anvendelse av preparatene
ATE26841T1 (de) Verbindungen zur behandlung von erhoehtem blutdruck.
US3629404A (en) Enzyme inhibitors 19 042 r.p. 21 052 r.p. and 21 053 r.p.
ATE94906T1 (de) Verfahren zur herstellung von l-alphaaminos|uren.
NO179209C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte silylalkylenaminer
Larner et al. ACTION OF INTESTINAL EXTRACTS ON “BRANCHED” OLIGOSACCHARIDES1
ES8405760A1 (es) Metodo para la preparacion de insulina humana semisintetica.
FR2355501A1 (fr) Nouvelles 2-(ethyl 2,2-disubstitue)-imidazolines, utiles notamment pour le traitement du diabete
US3875005A (en) Thrombolytic and fibrinolytic enzyme from streptomyces
EP0216467A3 (en) Two-dimensional diffusion glucose substrate sensing electrode
FR2356603A1 (fr) Procede de traitement des eaux residuaires par des levures
OA04679A (fr) Nouveaux esters et esteramides d'acides 0-triazololyl-thionophosphoriques (phosphoniques), leur procédé de préparation et leur application comme insecticide et acaricides.
FR2418235A1 (fr) Procede de preparation d'acides 7-imidazolidinyl substitue 3-chloro-3-cephem-4-carboxyliques et nouveaux produits ainsi obtenus, employes notamment comme agents antibacteriens

Legal Events

Date Code Title Description
ST Notification of lapse